by Silvia Prades | Nov 1, 2024 | Announcements
CureDRPLA was incorporated as a non-profit foundation in November 2019 by Paul and Andrea Compton. We are honoring 5 years of CureDRPLA with this impact report. In this report you will find a summary of our achievements to date and our goals for the next 5...
by Silvia Prades | Oct 16, 2024 | News Articles
CureDRPLA was founded in November 2019 and in light of our forthcoming founding anniversary, we have prepared an impact report to summarize our work and milestones. In this report you will find a summary of our achievements to date and our goals for the next 5 years....
by Silvia Prades | Oct 11, 2024 | Events
In this session, Dr Silvia Prades will give an update on the projects funded by CureDRPLA. Followed by a Q&A session with Dr Yael Shiloh-Malawsky from the University of North Carolina and Dr Hector Garcia-Moreno from University College London, two neurologists...
by Silvia Prades | Oct 2, 2024 | News Articles
Last week, Dr Silvia Prades attended a conference to find out more about the latest work on rare diseases and how the medicines regulatory framework is expected to change in the coming years to facilitate research and approval of treatments for rare conditions like...
by Silvia Prades | Aug 9, 2024 | News Articles
CureDRPLA co-founders, Paul and Andrea Compton, have a son with DRPLA and their personal experiences with this devastating condition are the driving force behind CureDRPLA. Earlier this year, CureDRPLA announced that n-Lorem had an experimental treatment for DRPLA and...
Recent Comments